S39 - Movement Disorders: Functional and Structural Imaging in Parkinson's Disease

Event Time: Thursday April 27, 2017 1:00 pm to 3:00 pm
Topic(s): Movement Disorders
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Volumetric analysis of limbic structures in patients with functional movement disorders Carine Maurer, MD, PhD
Dr. Maurer has nothing to disclose.

1:12 PM 002 Inferior parietal cortex as a hub of loss of inhibition and maladaptive plasticity Kristina Simonyan
Dr. Simonyan has received personal compensation for activities with Dystonia Medical Research Foundation as an advisor.

1:24 PM 003 Distinct Mesocorticolimbic blood flow response to dopamine therapy in patients with Parkinson′s disease and compulsive reward-driven behaviors Daniel Claassen, MD
Dr. Claassen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Neuroscience, Lundbeck, Acadia, and AbbVie. Dr. Claassen has received research support from NIH/NINDS, Michael J. Fox Foundation, Huntington Disease Society of America, Vaccinex, AbbVie, and Auspex Pharmaceuticals.

1:36 PM 004 Hippocampal and entorhinal cortex atrophy across the Parkinson′s disease cognitive impairment spectrum Roshni Patel, MD
Dr. Patel has nothing to disclose.

1:48 PM 005 The effects of different modalities of gait training on brain activation in patients with Parkinson′s disease: an fMRI study Inbal Maidan
Dr. Mirelman has nothing to disclose.

2:00 PM 006 Effects of Subthalamic Stimulation in Elderly patients with Parkinson′s Disease Vibhash Sharma, MD
Dr. Sharma has nothing to disclose.

2:12 PM 007 Identification of Usp8 as a toxicity modifying Deubiquitinase for α-synuclein Zoi Alexopoulou, MD, PhD
Dr. Alexopoulou has nothing to disclose.

2:24 PM 008 Glucose-regulated protein 78 (GRP78) in plasma and CSF is associated with Parkinson′s disease. Deepak Gupta, MBBS
Dr. Gupta has nothing to disclose.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses